Benefit decisions happen on a calendar. Pharmacy costs and formulary changes do not.
Open enrollment has a way of making benefits feel like a once-a-year event. For a few intense weeks, HR teams are moving, consultants are fielding questions, and employees are trying to understand what changed before the deadline closes.
They are not just comparing plan options. They are trying to avoid being surprised later by costs they did not see coming.
That pressure is already showing up in how employees approach enrollment. Voya reported that 77% of employed Americans planned to spend more time reviewing their benefit elections during annual enrollment to maximize their benefit dollars because of the economy. Premiums, deductibles, copays, networks, and prescription coverage all matter, and employees are right to look closely before making decisions that may affect their families for the next twelve months.
But open enrollment only selects the benefit. It does not freeze the pharmacy environment in place.
A plan can be chosen in November and tested in March. A member can make the best decision available during enrollment and still face a different reality later, when a medication changes tier, a lower-cost alternative becomes available, a specialty drug creates new pressure, or a formulary update changes what the plan is trying to manage.
That is where the real consequences start to show up.
The calendar closes. Pharmacy keeps moving.
Most employees are not thinking about formulary strategy during open enrollment. They are asking practical questions: What is changing? What will this cost me? Is my doctor in network? Are my family’s medications covered? Which plan is safest if something unexpected happens next year?
Those are reasonable questions, but they are still asked from a snapshot in time. Pharmacy does not work like a snapshot.
Formularies are updated. Drug costs shift. Preferred products change. New savings opportunities appear. Utilization patterns move. A medication that looked like the right cost decision at the beginning of the year may not stay that way all year.
RazorMetrics has written about this problem directly: “A formulary set once a year can’t track a market that moves every month.” That is not just a pricing issue. It is a benefits strategy issue. A static approach will always be reacting to yesterday’s pharmacy environment while members and plans are living in today’s.
For employers and consultants, that creates a timing problem. Open enrollment demands attention, but many pharmacy savings opportunities show up after the enrollment window has closed.
The member experience begins after enrollment
Open enrollment is when employees choose the plan. The member experience begins when they use it.
That is when the benefit becomes real: at the pharmacy counter, in the doctor’s office, during a refill, after a new diagnosis, or when a medication suddenly costs more than expected. A plan can look strong during enrollment and still create friction later if members are left to navigate pharmacy costs, formulary movement, and lower-cost alternatives on their own.
This is why benefits communication cannot be treated as a once-a-year exercise either. LIMRA found that 45% of employees only hear about their benefits during annual open enrollment, while 73% want benefits information several times a year. Employees already understand that benefit decisions do not stop mattering when the enrollment window closes.
The same should be true of pharmacy strategy.
The better question is not only, “Are we ready for open enrollment?” It is, “Are we ready for what happens after employees start using the benefit?”
Do not wait for the next cycle
Sometimes open enrollment is not the right moment to introduce a new pharmacy strategy. HR teams are overloaded. Member communications are packed. Consultants are trying to help clients get through the season cleanly. Adding another initiative during the rush may create more noise than value.
That does not mean the opportunity has passed.
When the smoke clears, there is a valuable window to look ahead. Where did pharmacy spend create pressure this year? Which drug categories are moving? Where are lower-cost, clinically appropriate alternatives being missed? Where is the current approach asking members to solve a problem that should have been addressed upstream?
That is the moment to move from enrollment execution to pharmacy strategy. The goal is not to chase the season. The goal is to be ready before the next set of pharmacy problems reaches members.
Where RazorMetrics fits
RazorMetrics is not limited to the open enrollment calendar. Pharmacy challenges happen throughout the year, and the solution is built for that reality.
We track PBM formulary changes behind the scenes, keep the solution current, and surface lower-cost, clinically appropriate alternatives closer to the prescribing decision before members are left to discover the problem at the counter.
That matters because pharmacy optimization should not depend on employees becoming experts in drug pricing, formularies, copay structures, or therapeutic alternatives. RazorMetrics puts the opportunity upstream, where physicians can make the clinical decision and employers can reduce avoidable spend without adding more work for members.
Whether an employer is preparing for open enrollment, in the middle of benefits season, or planning for the next benefit year after the rush, RazorMetrics can fit the schedule. The benefit calendar may be seasonal, but pharmacy cost, access, and savings opportunities are not.
Open enrollment will always matter. It is when employees make important choices and when employers communicate the value of their benefits investment. But the real test comes later, when someone needs the medication, fills the prescription, and sees whether the benefit works in real life.
That is where pharmacy strategy has to keep working, too.
